A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1226-1229

  Hertzberg, Michael A ^a,b   Butterfield, Marian I ^a,b   Feldman, Michelle E ^b   Beckham, Jean C ^a,b   Sutherland, Suzanne M ^a   Connor, Kathryn M ^a   Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Anticonvulsant; Kindling; Lamotrigine; Psychopharmacology; PTSD

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTICONVULSANTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; STRESS DISORDERS, POST-TRAUMATIC; TRIAZINES;

EID: 0033135984     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00011-6     Document Type: Article

References (35)

1. Brodsky L., Doerman A.L., Palmer L.S., Slade G.F., Munasifi F.A. Posttraumatic stress disorder An eclectic approach . Int J Psychosom. 37:1990;89-95.
2. Charney D.S., Deutch A.Y., Krystal J.H., Southwick S.M., Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry. 50:1993;294-305.
3. Connor K.M., Davidson J.R.T. The role of serotonin in posttraumatic stress disorder neurobiology and pharmacotherapy . CNS Spectrums. 3;7:(suppl 2):1998;42-51.
4. Connor KM, Davidson, JRT, Sutherland S, et al (1998): Pharmacotherapy for civilians with posttraumatic stress disorder: Differential response patterns to fluoxetine and placebo. Abstract No. 165, Poster Presentation 38th Annual NIMH-NCDEU Meeting, Boca Raton, Florida, June 10-13.
5. Davidson J, van der Kolk B, Brady K, Rothbaum B, Sikes C, Farfel G (1997): Double-blind comparison of sertraline and placebo in patients with posttraumatic stress disorder. Abstract at the European College of Neuropsychopharmacology Congress, Vienna, Austria, September 13-17.
6. Davidson J.R.T. Biological therapies for posttraumatic stress disorder An overview . J Clin Psychiatry. 58:(suppl 9):1997;29-32.
7. Davidson J.R.T., Malik M.L., Sutherland S.M. Response characteristics to antidepressants and placebo in post-traumatic stress disorder. Int Clin Psychopharm. 12:1997;291-296.
8. Davidson J.R.T., Smith R.D., Kudler H.S. Validity and reliability of DSM-III criteria for posttraumatic stress disorder. J Nervous Mental Dis. 177:1989;336-341.
9. Davidson J.R.T., Weisler R.H., Malik M., Tupler L.A. Fluvoxamine in civilians with PTSD. J Clin Psychopharm. 18:1998;93-95.
10. Dichter M.A., Brodie M.J. New antiepileptic drugs Review article . N Engl J Med. 334:1996;1583-1590.
11. Fatemi S.H., Rapport D.J., Calabrese J.R., Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry. 58:1997;522-527.
12. Fesler F.A. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry. 52:1991;361-364.
13. Ford N. The use of anticonvulsants in posttraumatic stress disorder Case study and overview . J Trauma Stress. 9:1996;857-863.
14. Friedman M.J. Current and future drug treatment for posttraumatic stress disorder patients. Psychiatric Annal. 28:1988;461-468.
15. Friedman M.J. Toward rational phamacotherapy for posttraumatic stress disorder an interim report . Am J Psychiatry. 145:1988;281-285.
16. Gilman J.T. Lamotrigine An antiepileptic agent for the treatment of partial seizures . Ann Pharmacother. 29:1995;144-151.
17. Hertzberg M.A., Feldman M.E., Beckham J.C., Davidson J.R.T. Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol. 16:1996;294-298.
18. Hertzberg M.A., Feldman M.E., Beckham J.C., Moore S.D., Davidson J.R.T. Open trial of nefazodone for combat-related posttraumatic stress disorder. J Clin Psychiatry. 59:1998;460-464.
19. Joffe R.T., Calabrese J.R. Anticonvulsants in Mood Disorders. 1994;Marcel Dekker, Inc, New York.
20. Kessler R.B., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the national comorbidity study. Arch Gen Psychiatry. 5:1995;1048-1060.
21. Lipper S. Carbamazepine in the treatment of posttraumatic stress disorder implications for the kindling hypothesis . Wolf M.E., Mosnaim A.D. Posttraumatic Stress Disorder Etiology, Phenomenology, and Treatment . 1989;185-203 American Psychiatric Press, Washington, DC.
22. Lipper S., Davidson J.R.T., Grady T.A., et al. Preliminary study of carbamazepine in posttraumatic stress disorder. Psychosomatics. 27:1986;849-854.
23. Marmar C.R., Schoenfeld F., Weiss D.S., Metzler T., Zatzick D., Wu R., et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry. 57:(suppl 8):1996;66-72.
24. Marshall R.D., Davidson J.R.T., Yehuda R. Pharmacotherapy in the treatment of posttraumatic stress disorder and other trauma-related syndromes. Yahuda R. Psychological Trauma. Review of Psychiatry, vol 17. 1998;133-177 American Psychiatric Press, Washington, DC.
25. Marshall R.D., Schneier F.R., Fallon B.A., et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol. 18:1998;10-18.
26. Post R.M., Weiss N., Smith M.A. Sensitization and kindling Implications for the evolving neural substrates of posttraumatic stress disorder . Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and Clinical Consequences of Stress From Normal Adaptation to PTSD . 1995;203-224 Lippincott-Raven, Philadelphia.
27. Post R.M., Uhde T.W. Carbamazepine in bipolar illness. Psychopharmacol Bull. 21:1985;10-17.
28. Resnick H.R., Falsetti S.A., Kilpatrick D.G., Freedy J.R. Assessment of rape and other civilian trauma-related PTSD. Miller T.W. Theory and Assessment of Stressful Life Events. 1996;235-271 International University Press, Madison.
29. Sheehan D., Janavs J., Knapp E., et al. Mini International Neuropsychiatric Interview, Clinician Rated, Version 4.4. 1994;University of South Florida College of Medicine, Tampa.
30. Solomon S.D., Davidson J.R.T. Trauma Prevalence, impairment, service use, and cost . J Clin Psychiatry. 58:(suppl 9):1997;5-11.
31. Sporn J., Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol. 17:1997;185-189.
32. Szymanski H.V., Herman V., Olympia J. Divalporex in posttraumatic stress disorder. Am J Psychiatry. 148:1991;1086-1087.
33. van der Kolk B.A. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 58:(suppl 9):1997;16-24.
34. van der Kolk B.A., Greenberg M.S. The psychobiology of the trauma response: Hyperarousal, constriction, and addiction to traumatic reexposure. van der Kolk B.A. Psychological Trauma. 1987;63-87 American Psychiatric Press, Washington DC.
35. Wolf M.E., Alavi A., Mosnaim A.D. Posttraumatic stress disorder in Vietnam veterans Clinical and EEG findings. Possible therapeutic effects of carbamazepine . Biol Psychiatry. 23:1988;642-644.